CreativeOne Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Sell
3,462
-38
-1% -$5.83K 0.01% 785
2025
Q4
$483K Buy
3,500
+955
+38% +$125K 0.01% 798
2025
Q3
$326K Buy
2,545
+88
+4% +$10.7K 0.01% 920
2025
Q2
$297K Sell
2,457
-20
-0.8% -$2.25K 0.01% 920
2025
Q1
$276K Buy
2,477
+197
+9% +$21K 0.01% 890
2024
Q4
$222K Sell
2,280
-4,492
-66% -$479K 0.01% 985
2024
Q3
$779K Buy
+6,772
New +$768K 0.03% 502
2024
Q2
Sell
-6,239
Closed -$604K 873
2024
Q1
$604K Buy
+6,239
New +$640K 0.02% 512
2023
Q3
Sell
-4,078
Closed -$412K 747
2023
Q2
$412K Sell
4,078
-373
-8% -$37.3K 0.02% 549
2023
Q1
$410K Buy
4,451
+1,466
+49% +$128K 0.02% 523
2022
Q4
$271K Buy
+2,985
New +$251K 0.01% 602
2022
Q3
Sell
-2,596
Closed -$219K 750
2022
Q2
$219K Sell
2,596
-720
-22% -$63.2K 0.01% 650
2022
Q1
$291K Sell
3,316
-1,710
-34% -$148K 0.02% 584
2021
Q4
$440K Buy
+5,026
New +$417K 0.02% 481
2021
Q3
Sell
-3,481
Closed -$317K 723
2021
Q2
$317K Sell
3,481
-126
-3% -$11.2K 0.02% 520
2021
Q1
$309K Buy
3,607
+422
+13% +$37.9K 0.02% 436
2020
Q4
$301K Buy
+3,185
New +$278K 0.02% 372

Other funds holding NVS

CreativeOne Wealth's NVS Position: Q1 2026 in Review

CreativeOne Wealth reduced its Novartis (NVS) stake by 1.1% in Q1 2026, selling an estimated $5.83K and leaving 3,462 shares worth $529K. The position accounts for 0.01% of the portfolio, ranked #785.

CreativeOne Wealth first reported a position in NVS in Q4 2020 and has held it in 17 quarters since. The position peaked at $779K in Q3 2024. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • CreativeOne Wealth held 3,462 shares of Novartis worth $529K as of Q1 2026.
  • CreativeOne Wealth sold 38 Novartis shares in Q1 2026, an estimated $5.83K.
  • Novartis made up 0.01% of CreativeOne Wealth's portfolio in Q1 2026, its #785 holding.
  • CreativeOne Wealth first reported a position in Novartis in Q4 2020 and has held it in 17 quarters since.
  • CreativeOne Wealth's Novartis position peaked at $779K in Q3 2024.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.